TP53 and pancreatic neoplasm: To investigate cellular and molecular events underlying the benign-to-malignant transition in pancreatic cancer, we employed the KPLOH model27 that enables identification and isolation of cells that undergo spontaneous loss of heterozygosity (LOH) of Trp53 (hereafter referred to as p53) during tumor initiation.